Skip to main content
Hana Pharm. Co., Ltd. logo

Hana Pharm. Co., Ltd. — Investor Relations & Filings

Ticker · 293480 ISIN · KR7293480000 KO Manufacturing
Open in API
Filings indexed 243 across all filing types
Latest filing 2021-11-02 Regulatory Filings
Country KR South Korea
Listing KO 293480

About Hana Pharm. Co., Ltd.

http://www.hanaph.co.kr/eng/index.do

Hana Pharm. Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and distribution of a wide range of medical products. The company specializes in anesthetics and narcotic analgesics, establishing a strong position in these therapeutic areas. Its portfolio also encompasses generic drugs, active pharmaceutical ingredients (APIs), antiemetics, and antibiotics. Focused on innovation, Hana Pharm's research and development pipeline includes novel drugs targeting the nervous system. Key projects under development are Byfavo Inj. (remimazolam), an ultra-short-acting anesthetic and sedative, and a new multi-functional MRI contrast agent. The company serves a global market and is expanding its capacity for injectable medicines to meet growing demand.

Recent filings

Filing Released Lang Actions
불성실공시법인지정
Regulatory Filings Classification · 100% confidence The document is a formal notification from the Korea Exchange (KRX) regarding the designation of Hana Pharm Co., Ltd. as an 'unfaithful disclosure corporation' due to a delay in disclosing business suspension. This is a regulatory announcement concerning compliance and legal/regulatory status, which fits the 'Regulatory Filings' (RNS) category as it does not fall into specific categories like legal proceedings (lawsuits) or management changes.
2021-11-02 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (674 characters) notifying the public about an upcoming Investor Relations (IR) event (a Non-Deal Roadshow). It provides the date, time, location, and purpose of the meeting, but it is not the presentation itself. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Report Publication Announcement (RPA) or a general regulatory filing. Given the specific nature of announcing an IR event, RPA is the most accurate classification.
2021-10-19 Korean
[기재정정]주요사항보고서(영업정지)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a business suspension (영업정지) due to regulatory administrative action. It is a formal regulatory disclosure of a material event, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, dividends, or financial reports.
2021-10-13 Korean
불성실공시법인지정예고
Regulatory Filings Classification · 100% confidence The document is a formal notice from the Korea Exchange (KRX) regarding the 'Notice of Designation as an Unfaithful Disclosure Corporation' for Hana Pharm. This is a regulatory announcement concerning compliance and disclosure violations. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-10-13 Korean
주요사항보고서(영업정지)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a business suspension (영업정지) due to a regulatory administrative action. Since this document details a specific regulatory event/legal matter involving the company's operations and does not fit into the other specific categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2021-10-13 Korean
매매거래정지및정지해제(중요내용공시)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension and resumption of trading for Hana Pharm Co., Ltd. due to a material disclosure (business suspension). It follows the standard format of a stock exchange regulatory announcement (RNS) rather than a full financial report or specific corporate action like a dividend or director dealing. Given it is a regulatory filing regarding trading status, it fits best under the RNS category.
2021-10-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.